当前位置:产品中心>单抗/多抗

Anti-Human HGFR/c-MET Reference Antibody|抗人HGFR/c-MET参考抗体(靶标:人间质-上皮转化因子(HGFR))

货号:RB9T37015153
  • 价格:面议
  • 点击数:630
  

产品介绍

产品参数

形态Liquid
宿主种属Humanized
克隆性Monoclonal
抗体亚型Fab-G1-kappa-[Fc-G1]
纯度>95% purity as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
浓度1mg/ml
内毒素水平Please contact the lab for this information.
应用ELISA, Bioactivity: FACS, Functional assay, Research in vivo
种属反应性Human
靶标Tyrosine-protein kinase Met, Hepatocyte growth factor receptor, Proto-oncogene c-Met, Scatter factor receptor, HGF receptor, SF receptor, HGF/SF receptor, MET
储存缓冲液0.01M PBS, pH 7.4.
稳定性和储存Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
表达系统Mammalian Cells
登录号P08581
背景信息Davutamig (REGN-5093) is a human immunoglobulin G4-kappa, anti-MET monoclonal antibody targeting two different nonoverlapping epitopes on MET. Davutamig is an antineoplastic.<br>• MET-dependent solid tumours - molecular diagnosis and targeted therapy., PMID:32514147<br/>• ABBV-399, a c-Met Antibody-Drug Conjugate that Targets Both <i>MET</i>-Amplified and c-Met-Overexpressing Tumors, Irrespective of <i>MET</i> Pathway Dependence., PMID:27573171<br/>• Fis1 phosphorylation by Met promotes mitochondrial fission and hepatocellular carcinoma metastasis., PMID:34848680<br/>• The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance., PMID:30786811<br/>• The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions., PMID:26822708<br/>• MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas., PMID:34667077<br/>• Targeting HGF/c-MET Axis in Pancreatic Cancer., PMID:33271944<br/>• Targeting the hepatocyte growth factor/Met pathway in cancer., PMID:28673936<br/>• Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases., PMID:30658428<br/>• Hepatocyte growth factor in physiology and infectious diseases., PMID:28094206<br/>
别名tMAb, OA-5DMe5, PRO143966, 1133766-06-9
备注For research use only. Not suitable for clinical or therapeutic use.